90 trials (keyword fallback)
Physical Disorders · Telemedicine
Primary: Emergency Department Use — 0.1050; 0.0885 Emergency dept use rate per person-month — p=0.017
Asthma
Primary: Number of Symptom-Free Days in the Prior 2 Weeks — 9.5; 10.1 days
Coronary Artery Disease
Primary: Accuracy (FTF Decision on Patient Disposition vs. V-visit Decision on Patient Disposition) — 89 percentage of agreement
Asthma in Children
Primary: Mean Symptom-Free Days in Prior 14 Days — 9.21; 8.21 days — p=.075
Autism Spectrum Disorder
Primary: Diagnostic Certainty: Tele-assessment — 3.07; 2.85 score on a scale (range 1-4)
Depressive Disorders · Alcohol Use Disorders · Post-traumatic Stress Disorder (PTSD)
Primary: Change in VR-12 Mental Component Summary Scores — 2.9; 5.1 score on a scale
Posttraumatic Stress Disorder
Primary: Change in PTSD Symptom Severity (PDS) — -5.31; -1.07 units on a scale — p=0.002
Opioid-use Disorder
Primary: Linkage to Medication for Opioid Use Disorder (MOUD) — 25; 47; 113; 89 Participants
PTSD
Primary: CAPS - PTSD Symptom Severity Score — 71.3; 72.5 units on a scale
Asthma · Chronic Obstructive Pulmonary Disease (COPD) · Congestive Heart Failure
Primary: Preventable Emergency Department (ED) Admissions — 0.038; 0.048 count of ED admissions per person per q — p=0.0793
Opioid Use · Opioid-use Disorder · Risk Reduction
Primary: Number of Participants Who Demonstrate no or Minimal Opioid Use at 3 Months — 6 Participants
Telemedicine Evaluation vs Telephone Evaluation
Primary: Functional Outcome (mRS(0-1)) at 6 Months After Index Event. The mRS is the Modified Rankin Scale That Measures Patient's Functional Level of Activity. The Scale is a 6…
Type 2 Diabetes Mellitus
Primary: Glycemia — 7.1; 7.6 percent of glycosylated hemoglobin
Pediatric Asthma
Primary: Average Number of Days Without Asthma Symptoms (Symptom Free Days) — 11.6; 10.97 Days — p=<0.05
Parkinson Disease
Primary: Feasibility of Virtual Visits for Parkinson Disease — 0; 95 participants